Imodium Smelt (Loperamide Hydrochloride)

Loperamide Hydrochloride acts on the gastrointestinal tract to control excessive bowel movements associated with diarrheal disorders.

• Acute diarrhea: reduces stool frequency and improves consistency.
• Chronic diarrhea: helps maintain regularity in long‑term conditions.
• Irritable bowel syndrome with diarrhea (IBS‑D): alleviates loose‑stool episodes and associated discomfort.

• Loperamide Hydrochloride binds to peripheral μ‑opioid receptors in the myenteric plexus, inhibiting acetylcholine release and decreasing intestinal smooth‑muscle activity. This slows gastrointestinal transit, allowing greater water absorption from the lumen and resulting in firmer stools. Its action is largely confined to the gut because it does not cross the blood‑brain barrier in significant amounts.

Loperamide is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

• Constipation: reduced bowel movements leading to hard stools.
• Abdominal cramps: mild to moderate discomfort in the abdomen.
• Nausea: feeling of queasiness.
• Dry mouth: reduced salivation.
• Dizziness: light‑headed sensation.
• Headache: mild to moderate pain.

Serious or Rare Side Effects

• Severe constipation or paralytic ileus: risk of bowel obstruction.
• Allergic reactions: rash, pruritus, or angioedema.
• Toxic megacolon: rare but life‑threatening colonic dilation.
• Cardiac arrhythmia: QT interval prolongation, especially with high doses or interacting drugs.

Loperamide should be used according to professional guidance and with awareness of specific safety considerations.

• Indication limitation: avoid use in infectious diarrhea with fever or blood.
• Hypersensitivity: discontinue if allergic reactions occur.
• Hepatic impairment: use with caution in patients with liver disease.
• Pediatric use: not recommended for children under 2 years of age.
• Drug dependence: avoid prolonged high‑dose use.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Loperamide may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase loperamide levels.
• CYP2C8 inhibitors (e.g., gemfibrozil): raise systemic exposure.
• Other antidiarrheal agents: risk of excessive slowing of gut motility.
• QT‑prolonging drugs (e.g., quinidine, haloperidol): may precipitate cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

• Anticholinergic medications: additive constipation.
• Opioid analgesics: enhanced central opioid effects.
• Rifampin: may reduce loperamide effectiveness by inducing metabolism.
• MAO inhibitors: potential for increased serotonergic activity.